I. lntroduction
At least four muscarinic rcceptors can now bc discriminatcd in radioligand experiments (Lazarcno and Robcrts, 1989; Michel et al., 1989; Lazarcno et al., 1990; Waelbroeck et aL, J990a) andin pharmacological studies (Dörje et al., 1990) . using a battery of sclcctivc antagonists. The M 1 receptors have the highest affinity for pirenzepine (Hammer et al., 1980) , the M 2 rcccptors, the highest affinity for AF-DX 116 (Giachdli et al., 1986 ) and the MJ and M 4 receptors have highcr affinities than M 2 receptors for 4-diphenylacetoxy Nmethyl piperidine methiodide (4-DAMP) (Barlow et al., 1976) and for hexahydro-sila-difenidol (Mutschler and Lambrccht, 1984; Lambrecht et al., 1989) . The cardioselectivc drugs himbacine (Gilani and Cobbing, 1986) and methoctramine (Melchiorrc et al., 1987) can be used to discriminate them from each other, bccausc they have a highcr affinity for M 4 than M ~ reccptors. Corr~spündcr.ce to: J. Christuphe Thc tissuc distribution and antagonist binding properlies of thc M 1 , M 2 , M ·' and M 4 rcccptors arc comparable to the tissue distribution of the m 1, m2, m3 and m4 mcsscngcr RNAs and to thc binding properlies of thc corresponding cloncd rcccptors cxpressed in different ccll lincs (Bonncr. 1989; Lcvinc and Birdsall, l W~9; Dörjc ct al., 1991 ) .
In thc last few ycars, data havc becn accumulatcd suggcsting tlmt the muscarinic reccptor subtypcs can also bc diffcrcntiatcd on thc basi~ of thcir st~rcosdc~ tivity (sec bclow ). A special vocabulary was introduced to dcscribc thcsc data (Lehmann, 1986) . The enantiomcr with thc highcr affinity for thc rcccptors is called thc ·eutomer', thc lcss affinitivc, thc 'distomcr'. Their affinity ratio ('cudismic ratio') is a mcasure of thc rcceptor's stcrcosclectivity. Its logarithm, thc 'eudismic indcx'. is proportional to thc differencc bctween the binding frec cncrgies of thc eutomcr and distomcr. Thc cudismic indcx of chirat muscarinic antagonists, such as procyclidine Mutschler, 1986~ Tackc et al., 1986; Waclbroeck et al., J 990b) , trihcxyphcnidyl and its mcthiodidc (Lambrecht et al., 1988) , biperiden (Eitze and Figala, 1988) , hcxahydro-t.ifenidol and hexhutinol (Fcifel ct al.. J 990) as weil as telenzepinc ( Evcleigh ct al., J 989) has be~n used as an additional critcl: .J.n for rcceptor classification. In thc case of muscarinic amagonists carrying a 1,3-oxathiolane nucl!.!us. therc was also a dcar-eut diffcrence bctween the cudismic affinity quoticnt (which measures the variation of thc cudismic index with cutomcr affinity) whcn comparing the muscarinic rcceptors in thc hcart, biadder or iieum (Gucilti(;ri d (iL, 1990) , supporting thc hypothesis that thcse reccptors arc different.
We compared in this work thc attm1ty and stercoselectivity of the enantiomers of scveral tcrtiary and quaternary chiral antagonists (sec fig. I ), all posscssing a hydroxy, phcnyl, and cyclohexyl group bound to the centre of chirality, but diffcring in thc structurc of thc basic amino (ammonium) group and thc structurc of the chain connecting the carbinol carbon atom and thc cationic hcad ( fig. 1 ). In addition. four analogues with a para-fluoro-phenyl rather than phcnyl group (fig. J) were invcstigated. Affinity data were obtaincd in competition experiments using [ ·'H]N-mcthyl scopolaminc as radioligand. Thc reccptors studicd were thc NB~OK 1 ncuroblastoma (M 1 ). rat cardiac (M 2 ), and pancrcas (i\! 3 ) reccptors, and the rat striatum receptors with M 4 binding propertic:;. Our goals wcrc 2-fold: (a) tcst the .... 0 I hypothesis that the receptor's stereoselectivity or eudismic affinity quotient can be used in combination with affinity valucs for reccptor classification; (b) obtam a better understanding of the basis of enantiomer discrimin~Hion by muscarinic receptors (binciing model).
The functional properties of the enantiomers of trihexyphenidyl (compound 1 in fig. 1 ) and its mcthiodidc (2) (L~r«biC'-~i~ ~~ al., 198~}. procyclidine (3) and tricyclamol (4) (Tacke ct al., 1986) . hexahydm-difenidol (5) as weil as hcxbutinol (9), its methiodide (10) and p-fluoro-hexbutinoi ( i i) {Ft;ifd ci aL, 199G) tü ums~ carinic receptor subtypcs havc been reportcd elsewhere. The binding affinities of the enantiomers of compounds 3 and 5-8 at muscarinic receptor subtypes havc also becn dcscribed (Waelbroeck et al., 1990b, 199la,b) .
Materials and :nethods

Ce/1 and tissue preparations
Human NB-OK 1 neuroblastoma cells (a generous gift from Dr. Yanaihara, Shizuoka, Japan) werc maintaincd in RPMI 1640 medium, enriched with 100 Ujml penicillin, 100 J.Lgfml Streptomycin and IOC:'r foctal calf serum (from Gibco, Gent, Belgium). Twice a weck the ceHs were detachcd by trypsin-EDTA (Gibco. Gent. Belgium) and divided 1/3. For [JH)N-methyl scopolamine ([ 3 H]NMS) binding experiments, the cells wcrc harvested using a 20 mM sodium phosphate buffcr enriched with 1 mM EDTA and 150 mM NaCI (pH 7.4), centrifuged at 500 X g for 5 min, resuspended and homogenized in 20 mM Tris-HCI buffer enriched w!th 5 mM MgCl 2 (pH 7.5) in a glass-Tetlon homogcnizcr, and then stored in liquid nitrogP.n until use.
For cardiac homogenates male Wistar albino rats (200-250 g) were killcd by decapitation, and thc hcart was immediately removcd and rinsed in 150 mM NaCI. The homogenization buffer containcd 20 mM Tris-HCI (pH 7.5) and 250 mM sucrose. Each hcart was homogcnized in 2 ml of this buffer with :.n Ultraturrax homogenizcr (maximal speed for 5 ::. 4°C) followcd by further addition of 13 ml of buffer, and 7 up and down strokes in a glass-Teflon homogenizer (at 4°C). The homogenate was fittered on two layers of medical gauze and either used immediately or stored in !iquid nitrogen until use.
For rat striatum homogenates thc brain was immediately removed and dissected. The striatum was homogenized in 2 ml of 20 mM Tris-HCI buffer (pH 7.5) enriched with 250 mM sucrosc, with a glass-Tcflon homogenizer, and stored in liquid nitrogcn until usc. These homogenatcs were diluted 20-fold with the homogenization buffer before use for [ 3 H]NMS binding experiments.
For rat pancreas homogcnates the organ was immediately removed, minced with ~·issors and homogcnized in a glass-Tcflon homogenizer (7 up and down strokes at 4°C) in a solution containing 300 mM sucrose, 0.2 mgjml bacitracin and 500 kallikrcin inhibitor U jml of Trasylol (Bayer, Brussels, Belgium). Thc resulting homogenate was immediatcly fittered on two layers of medical gauze and diluted 11-fold with thc incubation buffer.
/ 3 H/NMS binding experiments
[ ~H]NMS binding was measured at 25°C in a total volume of 1.2 ml using thc following incubation buffcr: 50 mM sodium phosphate (pH 7.4) enriched with 2 mM MgCI 2 , I% bovinc serum albumin (except when indicated) and the indicated tracer and drug concentrations. Addition of bovi:le serum albumin to thc incubation buffer increased [ 3 H]NMS binding very slightly (by at most 10-15%) and improved the reproducibility of duplicates in our filtration assays. In binding experiments on pancreas homogenates, we also addcd Trasylol and bacitracin (see above) to further inhibit proteolytic activity. Bovinc serum albumin was an essential ingredient in pancreas binding studies, sincc the binding capacity of pancrcao;; homogcnatcs disappcarcd within 40 min at room tcmpcraturc if this protcin was omittcJ from thc buffcr. hut was maintained over 9W/c for at least 4 h in its prcscncc.
To terminatc thc incuhation, cach samplc was diluted with 2 ml of icc-cold 50 mM sodium rhosphatc buffcr (pH 7.4) and filtcrcd on GF/C glass-li. ' 
l990a).
It is ncccssary to kccp traccr binding bclow Jsr;;. of thc total traccr addcd to avoid distortions of thc competition cuJVcs duc to traccr or unlabclled drug dcplction. This mcans that thc residual traccr hinding to striatum M 4 ( + M_.) sites in thc ahscncc of unlabcllcd drug must be maintaincd bclow srk. of thc total traccr added (i.c. 30%· of thc I5r;f· initial binding). Wc thcrcrorc dccidcd to usc a comparativcly high [ -'H]NMS conccntration (().25 nM, cquivatcnt to 5-fold K JJ at M 4 sitcs) for thcse expcrim~nts. In binding cxpcrimcnts on rat pancrcas homogenates we used 9RO J.L I of the homogcn<ttc pcr 1.2 ml samplc. Thc r'H]NMS conccntration v'a;o; 0.25 nM (2-fold Kn at M 3 rcccptors) and protcin concentration 800-1000 J.Lg pcr assay ( ~blJut 50 pM binding sitcs ). An incubation pcriod of 4 h was nccc.~ssary to allow hinding cquilibrium.
Protein conccntration was mcasurcd according to Lowry ct al. ( 1951) using bovinc scrum alhumin as standard.
Dma analysis and statistics
Thc compctition curvcs for unlabcllcd antagonists J-i 3 ( fig. 1) Thc (R)-and (S)-cnantiomcrs uf trihcxyphcnidyl ((R)-1 and (S)-1; as hydrochloridcs) (Schjcldcrup t:t al., 1987) and trihexyphenidyl mcthiodidc ((R)-2 and (S)-2) (Schjcldcrup ct al., 1987 and unpublished rc~uits) , procyclidinc ((R)-3 and (S)-3) (Tackc cl al., 1986) , tricy-TAULEI clamol iodide ((R)-4 and (S)-4) (Tackc ct al., 1986) , hcxahydro-difcnidol ((R)-5 and (S)-5; as hydrochloridcs) (Tacke ct al., 1989) , p-tluoro-hcxahydro-difenidol) ((R)-7 and (S)-7 as hydrochloridcs) (Strohmann ct al., 1991 ) , p-tluoro-hcxahydro-difenidol methiodide ((R)-8 and (S)~8) (Strohmann ct al., J 991), hcxbutinol ((R)-9 and (S)-9) (Tackc ct al., 1989) , hexbutinol methiodidc ((R)~IO and (S)-10) (Fcifcl ct al., 1990) , and p-tluoro-hcxbutinol (( R)-11 and (S)-11) (Strohmann ct al., 1991) and oxyphcncylimine ((R;-~3 and {S}·l~, as hydrochlorides) (Schjclderup ct al., 1988) were synthcsized according to thc literature. The (S)-enantiomer of p~fluoro-hcxbutinol methiodidc ((R)-12 and (S)-12) was also synthcsized according to thc Iiterature (Strohmann ct al.. 1991 ; in this papcr, the sign of thc optical rotation of (S)-12 is wrong; (S)-12 is not thc laevorotatory, but thc dextrorotatory enantiomer).
Thc cnantiomers of hexahydro-difcnidol methiodidc ((R)-6 and (S)-6) werc prcpar~d by quatcrnization of (R)-5 and (S)-5, respectively, with methyl iodide in acctone, following thc procedurc described for the synthcsis of (R)-8 and (S)-S (sec Strohmann et al., 1991) .
(R)-6: C 22 H_,r)NO (457.4), yicld 84%, m.p. 138-1390C (acctoncjdicUiyl cther, colourless needles), [a]~~6 = 14 (c = 0.5, CHCI_~) , ce > 99. 7%. Found: C, 57.4; H, H.3; N, 3.0. Calculated: C, 57.77; H. 7.93 ; N, 3.06. Structural charactcrization by 1 H and 1 -'C NMR spcctroscopic studics {data not givcn).
Thc (R)-cnantiomcr of p-fluoro-hcxbutinol mcthiodidc ((R)-12) was prepared by quaternization of(R)-11 pK, valucs of the (R)· and (S)·cnantiomcrs ur thc muscarinil" antagonists 1-U fur fuur muscarinic rcccptor suhtypcs. with methyl iodidc in acctonc, following the proccdurc described for the synthcsis of (S)-12 (see Strohmann et al., 1991 NMR spectroscopic sturlies ( data not given).
Results
General considerations
All the competition cutves obtained in this study were compatible with the existence of a single receptor subtype in thc different preparations with Hili coefficients not significantly different from unity (n 11 varied between 0.95 and 1.10, with Standard deviations below or cqual to 0.05 Competition cutves with (R)-anJ (S)-hexbutinol, (R)-and (S)-9 and (R)-and (S)-10-11 and -12 analogues and oxyphencycliminc ((R)-and (S)-13) were shifted to the right by 0.5-l.O log units in all preparations in the presencc of l% bovine scrum albumin (data not shown). We therefore determincd thc binding affinities of the enantiomers of compounds 9-13 to muscarinic receptors in homogenates from human NB-OK 1 cells, rat heart and striatum in the absence of bovint:: ~t::ruw albumin. pKi values are g:iven in table 1.
The binuing properties of the (R)-and (S)-cnantiomers of p-üuoro-hcxahydro-difenidol (7) and its mcthiodide (8) 
Receptur hinding profi/es of the ( R)-and (S)-cnanriomers
As shown in table l, thc rcccptor binding profiles of 
Stereosel:-ctirity at muscarinic receptors
Thc (R)-enantiomers (cutomcrs) of compounds 1-13 displaycd highcr affinities for M 1 -M 4 receptors than thc (S)-isomers (distomers), the eudismic indcxes varyEudismic indexes (differences betwccn the pKi valucs of thc (R)-and (S)-cnantiomcrs) of the antimuscarinics 1-13 at four muscarinic receptor subtypes. pKi Fig. 2 . The eudismic indt!xes of thc phenyl compounds 0-6. 9. 10 and 13) (circlcs) and the p-fluorophcnyl derivatives (7. 8. 11 and 12) {triangles) were plotted as a function of the cutomer affinity. The numbers identify thc compounds shown in fig. I ing by morc than two ot:dcrs of magnitudc. These observcd stercoselectivitic~• did not appcar to be associated in general with high affinity of the eutomer (sec below). M, a 'a' is thc eudismic index expected for a compound with a pKi = 0 (Ki \'aluc =I molar) and 'b', somctimes called 'cudismic affinity quotient', measures the slope of the line (i.e. the variation of stereoselectivity with affinity). h n.s. = not significant. methiodides 6 and 8 were very similar (1.9-2.6) at the four receptor subtypes. This was mainly based on the fact that N-methylation selectively increased the affinity of the (R)-enantiomcrs of thc tcrtiary amines 5 and 7 at M 2 receptors by more than one order of magnitude. The compounds 9-12 with a triple bond within the molecule had a lower eudismic index than the saturated drugs 1-8 (table 2) at all subtypes studicd. The samc held true for oxyphencyclimine at M 1 anci M 4 receptors.
Correlation of tlze eutomer affinity and eudismk index
We plotted in figs. 2 and 3 the eudismic index (difference between the pKi values of the (R)-and (S)-enantiomers) as a function of the affinity (pKi value) of the (R)-enantiomer (eutomer). We found no significant correlation between the affinity constants of either alt the eutomers or of all the unsubstituted eutomers 0-6, 9, 10, 13) and their eudismic indexes, at any subtype. Thanks to the presence of compounds 11 and 12 in our set of data, we were able to subdivide the data into two groups (by visual inspection) for analysis. The eudismic index of compounds 1-8 (table  1) did not vary significantly with the eutorner pK i value at M 3 receptors, and increased slightly with the pK i value at M 1 , M 2 and M 4 receptors. In contrast, the eudismic index of compounds 4, 9-13 and (at M 1 receptors only) 2 varied at least as much as the pKi value of the eutomer, at M 1 , M 2 and M 4 receptors.
The statistical parameters describing the regression lines (figs. 2 and 3) arc summarized in table 3.
Discussion
We investigate~ in this study the binding affinities of the enantiomers of oxyphencyclimine and of tertiary and quaternary compounds structurally relatcd to hexahydro-difenidol and hexbutinol at rnuscarinic M 1 (NB-OK 1 cells), M 2 (rat heart), M 3 (rat pancreas) and M 4 receptors (rat striatum). Our main goals were to test the hypothesis that cudismic analysis data may be used in receptor classification and to obtain more inforrnation about the enantiomer-discriminating properlies of muscarinic receptor subtypes.
Binding profile of the enantiomers and receptor classification
The subtype selectiv!ty of most of the enantiomers studied depended on their absolute configuration. The (R)-enantiomers of compounds 1-13 bad a greater affinity for M 1 -M 4 t('ceptors than the (S)-isomers (ta- 
Stereoselective interaction with musca;inic receptors
Four different groups are bound to the central carbon atom (centre of chirality) of the drugs {1-13) studied in this work: a protonated tertiary or a quater~ nary ammonium group, a hydroxyl moiety, a phenyl or p~fluorophenyl group, and a cyclohexyl group. Formation of an electrostatic interaction (protonated aminojammonium group) andjor hydrogen bond must be very important for binding: the cationic ammonium group and the hydroxyl group interact strongly with water when the drug is not bound. These interactions are disrupted when the drug reaches its binding site, and must therefore be replaced by strong interaction with the receptor. On the othcr hand, thc phcnyl and cyclohexyl groups do not interact favorably with water: dehydration per se is a favorable process. Binding can be further enhanced by close contact (van der Waals) interactions with the receptor, if the asymmetrically substituted carbon atom has the right absolute configuration (Waelbroeck et al., 1990b (Waelbroeck et al., , 1991 .
We have previously analyzed the binding properties of the enantiomers of procyclidine (3) and hexahydrodifenidol (5) and of structurally related achiral diphenyl and dicyclohexyl analogues (Waelbroeck et al., 1990b (Waelbroeck et al., , 1991b . Our results support the hypothesis that procyclidine and hexahydro-difenidol recognize four subsites of the muscarinic receptor, their stereoselectivity reflecting the stronger interaction of (R)-procyclidine ((R)-3) or (R)·hexahydro-difenidol ({R)-5) and weaker interaction of (S)-3 or (S)-5 with the two hydrophobic subsites.
Assuming that all the compounds studied here have the same binding pattern as procyclidine (3) and assuming that the ammonium groups of the two enantiomers form the same type of ionic bond, wc expected thc following results: (a) pairs of cnantiomcrs diffcring only in the structure of thcir amino (ammonium) groups should have thc samc cudismic indcx, at a ccrtain rcceptor subtypc; (b) the phcnyl group of the (R)-and (S)-enantiomcrs rccognizc, rcspectivcly, a phcnyl-prcfcrring and a cyclohexyJ .. prcfcrring subsitc (Waclbrocck ct al., l990b, l99Jb) . p-Fiuoro suhstitution might thcrcfore affcct diffcrcntly thc affinity of thc two cnantiomcrs and, as a rcsult, changc thc cudismic indcx of thc compounds. All p-tluoro derivatives, as a group, should however havc thc samc cudismic indcx at a particular subtype.
Some of our experimental results wcrc in good agreemcnt with thcsc prcdic\i!.'OS. There was littlc if any variation of the cudismic index of muscarinic M 1 • M 3 and M 4 rcceptors, for · procyclidine-likc derivatives' (compounds 1-K tablc 2). However, differcnccs in eudismic indcxes for compounds 1-H wcre obscrvcd at M.:! receptors (tablcs I and 2). This supportcd thc hypoihcsis that thc ionic bond bctwccn thc anionic subsitc of thc rcccpmr and thc cationic hcad of thc cnantiomers of thc muscarinic antagonists ( 1-8) is indcpcndent of thc drugs· absolute configuration, at least at M 1 , M 3 and M" rcccptors. p-Fiuoro substitution affected markcdly thc cudismic indcx of hexbutinol (9) and of hexbutinol methiodidc (10): thc phcnyl rings sccmcd to rccognizc a different rcgion of thc reccptor, depcnding on the absolute configuration of thc drug, and this was littlc affected by N-mcthylation.
On thc other hand: (a) N-rncthylation of hexahydro-difenidol {5-.. 6) and of p-fluoro-hcxahydrDdifenidol (7-+ 8) incrcased thc affinity of thc (R)-but not of the (S)-enantiomers for cardiac M 2 reccptors; (b} ihc cudismic indexcs of hexbütinol {9}, hcxbütino! methiodide ( 10) and oxyphencycliminc ( 13) wcrc significantly lowcr than thc cudismic indcxcs of thc compounds 1-8 at M 1 and M~ rcccptors; (c) p-fluoro substitution of hexahydro-difcnidol (5), hcxahydrodifcnidol mcthiodidc (6), hexbutinol (9) and hcxbutinol mcthiodidc (10) did not similarly affect thc binding properties of the four (R)-and (S)-enantiomcrs.
To account for thcsc discrcpancics, wc would likc to suggcst that thc position and conformation of cach compound within thc reccptor can bc adjusted to achievc an optimal overall frec cncrgy change. Whcn comparing thc enantiomcrs of procyclidinc (3) and tricyclamol (4), or trihexyphenidyl (I) and its methiodidc 2, for example, this is not a problcm: thesc compounds are quitc similar in sizc and flcxibility and probably rccognizc thc samc rcgion in thc muscarinic binding sitc. ln contrast, thc cnantiomcrs of hcxahydro-difcnidol (5), hexbutinol (9), thcir mcthiodidcs 6 and 10 and oxyphcncyclimine ( 13) arc greatcr in size andjor morc rigid moleculcs: oncc thc ionic bond between thc amino (ammonium) group and the anionic subsite of the rcceptor is formed the chiral centers of (R)· and (5)-5, 6. 9, 10 and 13 might be unable to reach thc same position as (R)-and (S)-procyclidinc. rcspectivcly. If. as a rcsult. thc two hydrophobic cyclcs of J -13 come in contact with different rcgions of a largc hydrophobic surfacc in thc musetuinie binding site, wc would cxpect: (a) different cudismic indexcs; and (b) different effccts of p-fluoro ~uhstitutinn on thc binding propcrtics of thc 'procyclidine-Iikc' drugs ( 1-8) and 'hcxbutinol-likc' drugs (9-13).
App/ication of Pfeiffer:'l· rufe mzd o.f its corollary
lt is often suggcsted (Lchmann, 1986 ) that the eudismic indcx increases linearly with eutomer potency, not only whcn comparing a series of rclatcd drugs interacting with a single rcceptor (this is known as • Pfciffcr's rulc ') but also whcn comparing thc interaction of a singlc pair of enantiomcrs with scvcral differ· cnt reccptors or rcceptor subtypcs. As cxplained by Bürlow ( 1990) , it is plausible that the !1ighcr the affinity of thc eutomcr of a chiraJ compot;nd, thc more it mattcrs how groups arc arrangcJ about thc cc~tre of chirality. This cxplains that. as a rule, thc cudismic indcx associatcd with chir:al drugs having a high affinity for the eutomer is largcr. Finding a linear corrciation between cutomcr affinity and eudismic indcx ls, howcvcr, far lcss likely: tlcxih~c molcculcs might hav~ grcatcr affini{!cs and lowcr cudismic indcxcs than morc rigid molcculcs, simply because both enantiomcrs are capablc of adapting their conformations to achievc a bctter fit with thc reccptors. \Ne cxpcctcd that finding a linear corrclation bctwecn cudismic index and affinity for a sei of molcculcs would givc valuable information about !hc drug-hinding piroccss. ln ord~r to tcst this hypothesis. wc rcprcscnted our data in figs. 2 and 3 and attcmptcd to find a corrclation bctwccn eudismic indcx and cutomcr affinity, cithcr for all compounds or for separate sets of thc drugs. We found good correlations when grouping compounds 1 -.. 8 and compounds (2) 4. 9-+13 in M 1 , M 2 and M 4 rcccptors (tablc 3).
Most of thc compounds in thc first group diffcr in thcir ammonium (protonatcd amino) group. Thc 'eudismic affinity quoticnt' (slope of the regression line) was small: thc affinitics of thc (R)-and of the (S)-cnantiomcrs varied in parallel. This is in good agrccmcnt with our hypothesis that the ionic bond is essential for binding of both enantiomers. Two p-fluoro derivatives 7 and 8 also fell in this group. As discussed abovc, we belicvc that. in order to allow the hydrogen bindings of thc OH group and the ionic intcractions of the ammonium moietics. thc phenyl group of (R)-hexahydro-difenidol ((R)-5) and (S)-5 recognizc different rcgions of the rcceptor, and that, by chance, p-fluoro substitution induced thc samc affinity loss at both subsites.
Thc sccond group includcd hexhutinol (9) derivatives and oxyphencyclimine ( 1 3), as weil as tricyclamol iodidc (4) and (in M 1 rcccptors) trihcxyphenidyl mcthiodidc (2). Thc cudismic indcx of thcsc drugs increased markedly with cutomer affinity.
Wc wcre not surprist'J to find in the sccond group hexbutinol (9) and its mcthiodidc ( 10) and thc p-tluorosubstitutcd derivatives 11 and 12. lndccd, if thc phcnyl rings of thc (R)-and (S)-configuratcd drugs rccognizc different sitcs in thc muscarinic rcccptor. p-tluoro substitution may afiect diffcrently the binding properlies of cach enantiomcr, and changc thc cudismic indcx (tablc 2). On thc othcr hand, wc did not cxpcct to find in thc same group cxyphcncycliminc ( 13), trihexyphenidyl mcthiodidc {2) and tricyclamol iodidc (4) which diffcr from hcxbutinol (9) by their ammonium (protonated amino) group.
We would likc to suggcst that thc protonatcd amino group of thc cnantiomers of hexbutinol (9) and oxyphencydiminc ( 13) forms ionic honds with an aspartatc rcsiduc of thc rcccptor. Duc to stcric hindrancc, thc positions of the asymmctricaJly substituted carhon atoms of, for cxamplc, the hcxbutinol or oxyphcncy· climinc enantiomcrs arc, thus. not idcntical with thosc of thc tricyclamol cnantiomcrs.
In conclusion: using pure cnantiomcrs rather than raccmic mixturcs can bc hclpful for rcccptor classifica· tion (thc cudismic indcxcs may scrve as an additional criterium for rcccptor subtype identification. and •he binding pattcrn of thc two enantiomcrs is somctimes vcry different). Corrclations betwccn thc eudismic indcx and high-affinity cnantiomcr potcncy. whcn prcscnt. should howcvcr bc intcrprcted only with thc grcatft e~t caution.
